Antacids Global Market Report 2023

Feb 2023| TBR518D| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
2) Distribution Channel: Hospital Pharmacies; Retail Pharmacies
3) By Formulation Type: Tablet; Liquid; Powder
Covering: GlaxoSmithKline plc; Pfizer Inc.; Bayer AG; Dr. Reddy's Laboratories Ltd.; AstraZeneca PLC

Antacids Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antacids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for antacids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antacids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Drug Class, By Distribution Channel, By Formulation Type
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.
Companies studied	GlaxoSmithKline plc; GSK; Pfizer Inc.; Bayer AG; Dr. Reddy's Laboratories Ltd.; AstraZeneca PLC; Boehringer Ingelheim GmbH; Sun Pharmaceuticals Industries Ltd.; Takeda Pharmaceutical Company Limited; Abbott Laboratories; WellSpring Pharm; Private Lable; Xiuzheng Pharma; Johnson & Johnson; Novartis Consurmer Health; CONBA; Reckitt Benckiser Group plc; Sanofi; Bausch Health; CR SANJIU; McNeil Consumer Pharmaceuticals Procter & Gamble; WalmartEquate; Chattem; Thornton and Ross Ltd.;

Scope

Markets Covered:

Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
By Formulation Type: Tablet; Liquid; Powder; Other Formulation Types

Companies Mentioned: GlaxoSmithKline plc; Pfizer Inc; Bayer AG; Dr. Reddy's Laboratories Ltd; AstraZeneca PLC

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Antacids Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Antacids Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : GlaxoSmithKline plc Financial Performance
Table 47 : Pfizer Inc Financial Performance
Table 48 : Bayer AG Financial Performance
Table 49 : Dr. Reddy's Laboratories Ltd Financial Performance
Table 50 : AstraZeneca PLC Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Antacids Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Antacids Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : GlaxoSmithKline plc Financial Performance
Figure 47 : Pfizer Inc Financial Performance
Figure 48 : Bayer AG Financial Performance
Figure 49 : Dr. Reddy's Laboratories Ltd Financial Performance
Figure 50 : AstraZeneca PLC Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Antacids Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR518C

Including: 1) Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
2) Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Others
3) By Formulation Type: Tablet; Liquid; Powder; Others
Covering: GlaxoSmithKline plc.; Pfizer Inc.; Bayer AG; Dr. Reddy's Laboratories Ltd.; AstraZeneca PLC.; Boehringer Ingelheim GmbH; Sun Pharmaceuticals Industries Ltd.

Antacids Global Market Report 2022 from The Business ...

Antacids Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Published Date - Apr 2021
Report Code - TBR518B

Including: 1) Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
2) Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Others
3) By Formulation Type: Tablet; Liquid; Powder; Others
Covering: GlaxoSmithKline plc; Pfizer Inc; Bayer AG; Dr. Reddy's Laboratories Ltd; AstraZeneca PLC

Antacids Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business ...

Antacids Global Market Report 2020

Published Date - Nov 2019
Report Code - TBR518A

Including: 1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents 2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others 3) By Formulation Type: Tablet, Liquid, Powder, Others
Covering: GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC

Antacids Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the ...